Factbites
 Where results make sense
About us   |   Why use us?   |   Reviews   |   PR   |   Contact us  

Topic: Ajay Piramal


Related Topics

In the News (Fri 27 Nov 09)

  
  The secret behind Ajay Piramal's success
Piramal is also the chairman of the group's retail operations, which are now looked after by his nephew.
There were many large suitors but Piramal decided to meet Mike Barker, the man in charge of selling the company, and told him that he had no track record, was only 33 but was confident of achieving his dream of putting Nicholas among the top five pharma companies in India (from 48th at that time).
We are through with the rather sumptuous lunch, and Piramal says his father had taught him an important lesson -- being with animals teaches you to have respect for all living things.
inhome.rediff.com /money/2005/nov/08lunch.htm   (1068 words)

  
 prdomain | features
Ajay Piramal: When you have been successful, I think it is the job of the leader to create a bigger vision.
At the end of the programme Harsha asked Ajay Piramal as how he would handle a situation when he finds that some day success won't be around.
The scion of Nicholas Piramal stated he was aware of the fact you may be a darling of the media and the public today and tomorrow you may not be there, so you have to be conscious of that.
www.prdomain.com /feature/feature_details.asp?id=47&area=G&typ=I   (799 words)

  
 CII ONLINE
Ajay Piramal, Chairman — CII National Committee on Drugs and Pharmaceuticals and Chairman, Nicholas Piramal India Ltd. highlighted some of the industry’s concerns regarding the proposed National Pharmaceutical Policy and regulatory aspects like price controls following an interactive session of the CII National Committee on Drugs and Pharmaceuticals, held today.
Piramal pointed out that any sudden regulatory shocks like increased price control would be detrimental to the industry and the economy.
Piramal drew attention to the fact that India is already emerging as a preferred destination for Life Sciences and at this inflection point; the industry needs large investments and government support to become a global player.
www.ciionline.org /news/newsMain15bd.html?news_id=718200640229PM   (340 words)

  
 Untitled Document   (Site not responding. Last check: 2007-09-13)
Piramal Holdings Limited, the development arm of Nicholas Piramal Group, is all set to expand its real estate operations.
The Nicholas Piramal Group is developing 25 lakh sq ft of space, most of which is property previously occupied by the company's textile mills and pharmaceutical plants.
The Ajay Piramal group company, the Morarjee Goculdas's textile mill at Lower Parel, spread over 10 lakh sq ft, is being converted into a residential complex of five 30-storey buildings.
www.hdfcrealty.com /general/news363.htm   (328 words)

  
 Nicholas Piramal India Limited
Ajay Piramal’s favourite story is “Foootprints on the sands of time”.
From owning what was then an almost defunct textile company, Piramal today is the chairman of a Rs 4,000-crore group, comprising Nicholas Piramal, the fourth-largest pharmaceutical company in India, Morarajee Weaving and Spinning and Gujarat Glass.
We are through with the rather sumptuous lunch, and Piramal says his father had taught him an important lesson — being with animals teaches you to have respect for all living things.
www.nicholaspiramal.com /media_archives8.htm   (965 words)

  
 Wharton India Economic Forum   (Site not responding. Last check: 2007-09-13)
Ajay Piramal is the Chairman and Managing Director of Piramal Enterprises Limited, a US$ 550 million industrial group with significant interests in pharmaceuticals, retailing, textiles and glass containers.
Ajay is 47 years old and holds a Master in Management Studies from Jamnalal Bajaj Institute of Management Studies, University of Bombay (1978); he has completed the Advanced Management Programme from the Harvard Business School in 1992.
His wife, Dr. Swati Piramal holds an MBBS, DIM and M.P.H., from the Harvard University and holds the position of Director, Strategic Alliances in NPIL.
www.whartonglobal.com /wgbf2003/india/piramal.asp   (465 words)

  
 Glass Asia   (Site not responding. Last check: 2007-09-13)
Nicholas chairman Ajay Piramal has decided to spin off this Rs 260 crore (Rs 2.6 billion) glass business, in a move which he believes will help Nicholas Piramal improve its return on net worth and capital employed.
The Piramals held 51.31% stake in Nicholas Piramal as on March 31, 2003.
Currently, Nicholas Piramal holds 53.8% stake in Gujarat Glass, while the rest is held by JP Morgan and other institutional funds.
www.asiaglass.com.sg /asgnews/shownews.asp?messageID=333&direction=1   (312 words)

  
 Rediff On The Net Business Interview: Ajay Piramal on how India can become competitive in the world market
Piramal, who has gained a tremendous reputation after acquiring dying pharmaceutical firms and turning them around into profit centres, has firm views on the urgent need to adapt and change for India to be competitive into the next century.
Piramal was particularly harsh on the government's inability to prepare for globalisation.
Piramal is worried that despite the need to be globally competitive today, unions are slow in responding to the changing times.
www.indiaabroad.com /business/oct/31ajay.htm   (1918 words)

  
 Growth is a way of life   (Site not responding. Last check: 2007-09-13)
Piramal took over the company when it was facing criminal and civil cases.
Piramal is getting ready for the year 2005 when the GATT agreement comes into effect.
Piramal had demonstrated his management and marketing skills when he acquired the Swiss giant Roche which couldn’t introduce any new product in the market for 16 years.
www.pugmarks.com /week/mar09/industry.htm   (1376 words)

  
 The Telegraph - Calcutta : Business
July 18: The government plans to bring 33 per cent of all medicines produced in the country under price control ?and a decision on this contentious proposal could be taken by the cabinet within the next 15 days.
Ajay Piramal, who heads Nicholas Piramal (India) and is chairman of the CII national committee on drugs and pharmaceuticals, said, “The current price control regime has worked well.
Piramal said instead of stunting growth by placing fetters on industry through over regulation, the government should allow the market forces to determine prices.
www.telegraphindia.com /1060719/asp/business/story_6496696.asp   (591 words)

  
 || Businessworld - Play the game ||
Piramal desperately needed someone as a span-breaker for Shah, but he found none in the industry.
Piramal may be convinced about them, but the recruitment of former consultants in key positions has sent ripples through the company.
But Piramal himself, having given too free a rein to his top managers in the past, is a lot more hands-on today, and an active reviewer.
www.businessworldindia.com /Dec2203/indepth02.asp   (1953 words)

  
 Nicholas Piramal India Limited
Nicholas Piramal India Limited (NPIL) is India's second largest Pharmaceutical Healthcare company is a leader in the Cardio-vascular segment.
Ajay Piramal, who is also the Chairman of NPIL, and among the most respected names in Indian industry.
Ajay Piramal, who is also the Chairman of NPIL.
www.nicholaspiramal.com /media_companyprofile.htm   (536 words)

  
 Nicholas Piramal to hive off glass, bulk drugs divisions into subsidiaries
The consideration received could see the Ajay Piramal group launch a major offensive on the acquisition front, both for brands and companies with a strategic fit.
Piramal said the spinoff of the glass unit was being done since it was capital-intensive and a standalone company would provide more focussed attention and increased growth prospects in Australia and south-east Asia.
Nicholas Piramal is also working on a second alliance for an entry into the US market, which again will involve an equity tie-up.
www.expressindia.com /fe/daily/19980221/05255524.html   (607 words)

  
 Analyst Meet   (Site not responding. Last check: 2007-09-13)
Addressing analysts on the half-yearly performance of the company, Ajay Piramal, Chairman, Nicholas Piramal, said the company is set to leverage its MandA skills in a highly fragmented industry.
Piramal said the ICI Pharma division has been degrowing at a rate of 23%.
Piramal said development is underway for two cardiovascular, 1 diabetes and 1 anti-fungal NCE compounds.
www.indiainfoline.com /meet/me546.html   (1363 words)

  
 [No title]
Ajay: I don't think that can happen, post-2005, as there is so much competition today.
Ajay: The other issue is on patents; we need a much stronger and bigger patent office because it is just too archaic.
Ajay: Our policy is clear, if there is a strategic fit, if there is a willing seller and if it makes economic sense for us, we would go in for it.
www.hinduonnet.com /thehindu/thscrip/print.pl?file=2004050701970200.htm&date=2004/05/07/&prd=bl&   (922 words)

  
 India Education Initiative .. || .. About Us :: People   (Site not responding. Last check: 2007-09-13)
Ajay Piramal is Chairman of Piramal Enterprises Ltd., a Rs.2000 crore group with interests in pharmaceuticals, healthcare, research, retailing, textiles, glass containers, auto components, cutting tools, and ferrites.
Piramal is a trustee of a number of charitable institutions.
Piramal holds a bachelors degree in science from Bombay University and a masters degree in Management Studies from the Jamnalal Bajaj Institute of Management Sciences.
www.indiaeducationinitiative.org /people.htm   (1702 words)

  
 Ajay Piramal to get lion's share- The Times of India   (Site not responding. Last check: 2007-09-13)
Ajay and his wife Swati, who plays a prominent role in the group, have one son, Anand, who's in school in US.
Over the last decade, Ajay Piramal has emerged as one of India Inc's best-known faces, aggressively transforming what was originally a textile group into a Rs 3,500-crore conglomerate with interests in pharmaceuticals, retailing, construction and engineering.
Nicholas Piramal, which came into being in the late nineties with the acquisition of Nicholas Laboratories from Sara Lee, has grown into one of the country’s five largest pharma companies.
timesofindia.indiatimes.com /articleshow/965795.cms   (378 words)

  
 Business World - Cover story
Adds the insider: "Piramals' Hoechst connection cannot be understated here and Hoechst has already joined hands with Rhone Poulenc worldwide." Piramal had earlier bought Hoechst research lab at Mumbai for Rs 20 crore and snapped up a few brands as well.
Piramal, after nearly a decade as a poor tenth in the ORG pharma hustings, will now move up to the fourth slot after Glaxo, Cipla and Ranbaxy (though the company claims that it will be No. 2).
Piramal's agility in any takeover has always been his clean balance sheet and loads of cash at any given point of time.
www.businessworldindia.com /archive/010115/mktg7.htm   (809 words)

  
 Untitled Document   (Site not responding. Last check: 2007-09-13)
Piramal Holdings Ltd plans to develop a residential complex out of its 41,000 square metre freehold property at the Bhandup suburb in Mumbai.
Bhandup is the latest addition to the list of suburban locations that have witnessed to an increase in development activities in the recent past.
Piramal Holdings is on the verge of finalizing the purchase deal with Nicholas Piramal India Ltd (NPIL) for the Bhandup property for a consideration of Rs 13 crore.
www.hdfcrealty.com /general/news276.htm   (246 words)

  
 Moneycontrol.com - News, Nicholas approves Rs 350cr rights issue - IPO, TAX, Income Tax, Provides comprehensive ...
Nicholas Piramal is raising around Rs 350 crore through a rights issues to ramp up investments in manufacturing and research.
Piramal said, "Looking at it from the shareholders angle, we feel it makes more sense not to dilute the value of the shareholders at a time when we feel there is much to the company than just a 14% annualised return."
Piramal said that a few deals are now lined up with top Japanese companies.
ipo.moneycontrol.com /backends/News/frontend/news_detail.php?autono=163706   (603 words)

  
 FAG   (Site not responding. Last check: 2007-09-13)
After divesting off its textiles and tools divisions, and merging a property developing outfit of Ajay Piramal, the performance has worsened.
The Ajay Piramal group has taken the lead by merging its two real estate ventures under a single entity.
Piramal Holdings has already obtained the rights for developing Swan Mills at Lower Parel.
www.sloppyinvestor.com /mr.htm   (347 words)

  
 Nicholas Piramal develops novel anti-cancer drug   (Site not responding. Last check: 2007-09-13)
Pharma major Nicholas Piramal India Ltd has claimed to have developed a novel anti-cancer drug to arrest and regulate the multiplication of cancer cells.
Described as an important therapeutic advance in the treatment of cancer, the anti-cancer compound -- C 77 Novel cyclin-dependent kinase 4 (Cdk4) inhibitor -- was presented by Dr Kalpana Joshi, principal scientist, at the ongoing International Conference on 'Molecular Targets and Cancer Therapeutics' held in Boston, USA, an NPIL release in Mumbai said.
NPIL Chairman Ajay Piramal said, "The world is currently witnessing critical innovations and new knowledge in cancer research.
www.rediff.co.in /money/2003/nov/18cancer.htm   (310 words)

  
 Supermarket down your street   (Site not responding. Last check: 2007-09-13)
Piramyd Supermarkets the Ajay Piramal controlled retailing venture plans to become the 7-Eleven of India by opening a chain of 125 neighborhood convenience stores across Mumbai and Pune over the next three years.
Taking it well beyond the group’s Crossroads mall, Piramal is planning to set up 16 more stores each costing Rs 20 crore (see box) over the next three years.
Piramal will spend between Rs two crore to three crore per 10,000 square feet Jammin’ that’s set up as a shop-in shop inside the megastore.
midday.chalomumbai.com /news/business/2004/october/94473.htm   (657 words)

  
 Nicholas piramal buys-out partner’s 50% in Sarabhai piramal pharmaceuticals for rs. 693 million
Nicholas piramal buys-out partner’s 50% in Sarabhai piramal pharmaceuticals for rs.
Ajay Piramal, Chairman, NPIL said, “The SPPL buy-out is in-line with Nicholas Piramal’s objective of consolidating its pharmaceuticals portfolio.
Ajay Piramal, who is also the Chairman of NPIL, and among the most respected names in Indian industry.
www.prweb.com /releases/2003/12/prweb96196.htm   (440 words)

  
 Sharekhan.com   (Site not responding. Last check: 2007-09-13)
MUMBAI, JAN 28: Nicholas Piramal India Ltd (NPIL) has registered 76.12 per cent increase in net profit at Rs 37.32 crore for the third quarter ended December 31, 2003 as compared to Rs 21.19 crore in the corresponding period of the previous fiscal.
Ajay Piramal, chairman, NPIL, stated, NPILs differentiated business strategy has now taken deep roots.
The board of NPIL on Wednesday also approved merger of Sarabhai Piramal Pharmaceuticals Pvt Ltd with NPIL with effect from April 1, 2003.
content.sharekhan.com /Sharekhan/NewsViewpointsArticles/0,1567,3029004027~NEWS,00.html   (329 words)

  
 rediff.com: DSP's Kothari, Ajay Piramal have FM channel pie
While Kothari and Piramal are the actual financiers of the channel, with stakes of 60 per cent and less then 30 per cent, respectively, the day-to-day affairs is run by Radia.
Sources close to Kothari say his investment in the FM channel was not motivated by financial returns but because of a close equation with Radia.
But not so in the case of Piramal though, who said: "The investment is driven purely by financial considerations.
www.rediff.com /money/2002/jul/23fm.htm   (372 words)

  
 Nicholas Piramal   (Site not responding. Last check: 2007-09-13)
Nicholas Piramal is one of the largest pharmaceutical companies of India.
It was acquired by the Piramal group in 1988 and was renamed as Nicholas Piramal India Limited.
As a result Nicholas Piramal, which is earning nearly 70 percent of its sales from formulations is facing increasing competition.
www.karvy.com /compresearch/company/nicholas%20piramal/New%20Nicholas%20Piramal.htm   (676 words)

  
 Nicholas Piramal targets 20 per cent sales growth during current fiscal   (Site not responding. Last check: 2007-09-13)
Mumbai, Aug 9: Nicholas Piramal expects to register a sales growth of 20 per cent for the current fiscal as against the average industry growth rate of roughly 10 per cent.
Nicholas Piramal chief scientific officer Dr Swati Piramal said that Aablaquin had been launched in the Thane zilla parishad and an all-India launch would be complete by August 27.
Nicholas Piramal chairman Ajay Piramal said that the group would decide by this year on whether to make further investments or merely exit the venture.
www.indianexpress.com /fe/daily/20000810/fex10034.html   (538 words)

  
 Piramal Group under restructuring mode - Tirupur Exporters' Association, India   (Site not responding. Last check: 2007-09-13)
While Ajay Piramal remains the chairman of all group companies, the family has given independent charge of the real estate business to Rajeev Piramal, the son of Urvi Piramal, Ajay Piramal's sister-in-law.
Harsh Piramal, Urvi Piramal's eldest son, who was earlier looking after some of the pharmaceutical business of Nicholas Piramal India (NPIL), the pharma flagship of the group, has been given independent charge of Morarjee Textiles and the group's engineering business.
The Piramal group's engineering business is spread over two different companies, CMP Auto and GP Electronics, and another division Miranda Tools, which is a part of NPIL.
www.tea-india.org /detailnews.asp?show=more&nid=2888   (533 words)

  
 Split reports baseless: Ajay Piramal- The Economic Times   (Site not responding. Last check: 2007-09-13)
MUMBAI: Piramal Enterprises Ltd on Tuesday said the Piramal group has put in place a strong management team to run businesses, including pharma and textiles, to take benefit from opportunities emerging from new patent regime and dismantling of multi-fibre agreement (MFA).
Ruling out any split in the Piramal family, PEL's Chairman Ajay G Piramal and vice Chairperson Urvi A Piramal in a joint statement here said speculation about a split in a section of media was "wrong and baseless".
Urvi Piramal is also on the board of Nicholas Piramal India Ltd, a pharma company, and Gujarat Glass Ltd as also other companies of PEL, the statement adding that the Piramal familiy members continue to hold shares in various group companies.
economictimes.indiatimes.com /articleshow/966831.cms   (259 words)

Try your search on: Qwika (all wikis)

Factbites
  About us   |   Why use us?   |   Reviews   |   Press   |   Contact us  
Copyright © 2005-2007 www.factbites.com Usage implies agreement with terms.